Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.66B | 2.52B | 2.08B | 1.73B | 1.43B | 1.02B |
Gross Profit | 1.45B | 924.63M | 756.52M | 596.21M | 441.15M | 360.06M |
EBITDA | 645.58M | 598.63M | 497.60M | 418.32M | 186.62M | 235.58M |
Net Income | 50.49M | 94.67M | 61.04M | 163.26M | 65.87M | 68.10M |
Balance Sheet | ||||||
Total Assets | 9.89B | 9.65B | 7.25B | 6.38B | 5.46B | 4.53B |
Cash, Cash Equivalents and Short-Term Investments | 203.55M | 540.20M | 838.79M | 992.72M | 386.96M | 312.65M |
Total Debt | 3.87B | 3.46B | 2.16B | 2.16B | 1.68B | 1.69B |
Total Liabilities | 8.83B | 8.55B | 6.27B | 5.57B | 4.86B | 4.46B |
Stockholders Equity | 542.52M | 627.66M | 559.75M | 478.40M | 343.77M | 69.79M |
Cash Flow | ||||||
Free Cash Flow | 432.48M | 467.87M | 447.43M | 320.47M | 263.71M | 122.89M |
Operating Cash Flow | 488.58M | 514.87M | 477.20M | 335.51M | 273.49M | 135.39M |
Investing Cash Flow | -2.32B | -1.76B | -476.23M | -22.42M | -457.94M | -865.42M |
Financing Cash Flow | 1.51B | 1.17B | -12.61M | 314.76M | 429.28M | 989.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $6.51B | 9.12 | 15.12% | 1.91% | 4.64% | 15.36% | |
79 Outperform | $6.04B | 8.72 | 13.29% | 2.08% | 9.87% | 3.41% | |
74 Outperform | $9.71B | 14.93 | 13.20% | 1.67% | 6.18% | -10.34% | |
69 Neutral | $15.15B | 13.63 | 14.72% | 3.62% | 4.40% | 33.32% | |
68 Neutral | $6.44B | 41.28 | 3.23% | 3.60% | 0.96% | -27.04% | |
65 Neutral | $17.42B | 8,970.27 | 9.23% | 0.73% | 21.56% | -21.27% | |
61 Neutral | C$14.63B | 6.11 | 22.26% | 5.61% | 27.38% | -22.40% |
On May 30, 2025, Ryan Specialty Holdings, Inc. held its annual meeting where stockholders approved multiple amendments to the company’s Certificate of Incorporation and bylaws. These changes include declassifying the Board of Directors, adopting a majority voting standard for uncontested director elections, and allowing stockholders to call special meetings and take action by written consent. Additionally, the amendments set a sunset date for the voting disparity between Class A and Class B shares and provide for the exculpation of certain officers under Delaware law. These amendments aim to enhance corporate governance and align with market standards, potentially impacting the company’s operational flexibility and shareholder engagement.
The most recent analyst rating on (RYAN) stock is a Hold with a $60.00 price target. To see the full list of analyst forecasts on Ryan Specialty Group stock, see the RYAN Stock Forecast page.